<--- Back to Details
First PageDocument Content
Psychiatric diagnosis / Morphinans / Pharmaceuticals policy / RTT / Clinical pharmacology / Prescription monitoring program / Medical prescription / Prescription drug / Naloxone / Drug Enforcement Administration / Heroin / Opioid
Date: 2016-03-07 15:17:14
Psychiatric diagnosis
Morphinans
Pharmaceuticals policy
RTT
Clinical pharmacology
Prescription monitoring program
Medical prescription
Prescription drug
Naloxone
Drug Enforcement Administration
Heroin
Opioid

Alaska Controlled Substances Advisory Committee White Paper

Add to Reading List

Source URL: www.law.alaska.gov

Download Document from Source Website

File Size: 432,13 KB

Share Document on Facebook

Similar Documents

Prescription Drug Monitoring Program Facts, Figures, and Trends 2nd Quarter 2017 North Dakota Board of Pharmacy Kathy Zahn, RPh Tech, CPhT, Program Administrator 1906 E. Broadway Ave

DocID: 1vfFG - View Document

REGISTRATION FOR THE MISSISSIPPI PRESCRIPTION MONITORING PROGRAM (PMP) Enter the MSPMP link below in your internet browser: https://mississippi.pmpaware.net/login Click on create an account. Input your personal email add

DocID: 1vf1f - View Document

Bill 3824: Prescription drug monitoring program

DocID: 1uVvP - View Document

SUBJECT: Mississippi Prescription Monitoring Program (MPMP) Advisory Committee DATE:

DocID: 1uQ69 - View Document

Chapter 25.2 of Title 54.1 of the Code of Virginia Prescription Monitoring Program Table of Contents Chapter 25.2 of Title 54.1 of the Code of Virginia 1

DocID: 1uB5B - View Document